• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » More Than 80 COVID-19 Vaccines in Clinical Trials, Research Shows

More Than 80 COVID-19 Vaccines in Clinical Trials, Research Shows

March 8, 2021

As of March 1, there were 308 COVID-19 vaccine candidates with 81 in clinical trials, according to a new vaccine trial tracker.

Of those trials, there were 24 in phase 1, 26 in phase 1/2, seven in phase 2, 16 in phase 3 and four in phase 4. Four studies were terminated. Twelve of the tracked vaccines are currently being administered to the public, but trials are ongoing with several of them.

Of the more than 300 vaccine candidates tracked, 38 were RNA-based and 26 were DNA-based. Other vaccine types include nonreplicating vector (37), replicating vector (24), inactivated (20), live-attenuated (4), protein subunit (99), virus-like particle (22) and other/unknown (39).

The statistics come from researchers at the University College London and the London School of Hygiene & Tropical Medicine (LSHTM), which recently launched the trial tracker. It is hosted by the Vaccine Centre at LSHTM and is updated weekly, gathering information on all preclinical and clinical candidates from the World Health Organization’s tracker database, as well as the Milken Institute’s COVID-19 treatment and vaccine tracker. It also includes information provided directly by sponsors.

View the LSHTM tracker here: http://bit.ly/3sNMAZG.

COVID-19
  • Related Directories

    Veklury (remdesivir)

    Pfizer-BioNtech COVID-19 Vaccine

    Moderna COVID-19 Vaccine (mRNA-1273)

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing